ArticleBreast cancer research and treatment2023

Neoadjuvant pegylated liposomal doxorubicin- and epirubicin-based combination therapy regimens for early breast cancer: a multicenter retrospective case-control study.

Jui-Hung Tsai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.